Patent Assignment
Reel/Frame 027133/0506
Corrective Assignment to Correct the Typographical Error in the Assignee Name - Case Management Technologies, Inc. Previously Recorded on Reel 027123 Frame 0970. Assignor(S) Hereby Confirms the Assignee Name Should Be Care Management Technologies, Inc..
Recorded: 2011-10-27
Pages: 6
Assignor
OXFORD FINANCE LLC (SUCCESSOR IN INTEREST TO OXFORD FINANCE CORPORATION), AS AGENT
Executed: 2011-10-21
Assignees
COMPREHENSIVE CLINICAL DEVELOPMENT, INC. (FKA COMPREHENSIVE NEUROSCIENCE, INC.)
3100 SW 145TH AVENUE, SUITE 340, MIRAMAR, FLORIDA, 33027
CARE MANAGEMENT TECHNOLOGIES, INC.
3100 SW 145TH AVENUE, SUITE 340, MIRAMAR, FLORIDA, 33027
Covered Properties
(3)
System and method for targeted interventions of physician prescription practices based on deviations from expert guidelines
Application:
09/968,726 →
Publication:
US 2002/0143579
Augmentation of Atypical Antipsychotic Agent Pharmacotherapy with Chromium Supplementation
Augmentation of Atypical Antipsychotic Agent Pharmacotherapy with Chromium Supplementation
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 31, 2001
From: DOCHERTY, JOHN P.
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 012410/0726 →
Assignment of Assignor's Interest
Apr 2, 2002
From: SURLES, RICHARD; CARPENTER, DANIEL
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 012747/0814 →
Assignment of Assignor's Interest
Aug 23, 2002
From: DOCHERTY, JOHN
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 013224/0519 →
Assignment of Assignor's Interest
Jan 5, 2005
From: DOCHERTY, JOHN
To: COMPREHENSIVE NEUROSCIENCE, INC.
Reel/Frame 015540/0426 →
Assignment of Assignor's Interest
Apr 23, 2009
From: COMPREHENSIVE NEUROSCIENCE INC.
To: CARE MANAGEMENT TECHNOLOGIES, LLC
Reel/Frame 022588/0838 →
Security Agreement
Jan 28, 2011
From: COMPREHENSIVE NEUROSCIENCE, INC.; CARE MANAGEMENT TECHNOLOGIES, INC.
To: OXFORD FINANCE CORPORATION, AS AGENT
Reel/Frame 025714/0331 →
Release of Security Interest
Oct 26, 2011
From: OXFORD FINANCE LLC (SUCCESSOR IN INTEREST TO OXFORD FINANCE CORPORATION), AS AGENT
To: COMPREHENSIVE CLINICAL DEVELOPMENT, INC. (FKA COMPREHENSIVE NEUROSCIENCE, INC.); CASE MANAGEMENT TECHNOLOGIES, INC.
Reel/Frame 027123/0970 →